Superoxide Generation by Clastogenic Factors

  • Ingrid Emerit
  • Arlette Levy
  • Shahid Khan
Part of the NATO ASI Series book series (NSSA, volume 189)


Chromosome breakage factors or clastogenic factors (CF) were first described by radiobiologists, who reported a chromosome damaging effect of plasma from irradiated persons (for review see 1). These authors insisted on the long lasting nature of this phenomenon and suggested that CF may be risk factors in the development of late neoplasias resulting from therapeutic or accidental irradiaton. Renewed interest in diffusable CF paralleled the recognition of clastogenic activity in the plasma of patients with the socalled congenital breakage syndromes, ataxia telangiectasia (2) and Bloom’s syndrome (3), and in acquired diseases with increased chromosome damage, such as chronic inflammatory diseases of the connective tissue, the intestinal tract and the nervous system (for review see 4). CF may be isolated not only from plasma, but also from synovial fluid and cerebrospinal liquor.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    G.B. Faguet, S.M. Reichard and D.A. Welter. radiation-induced clastogenic plasma factors. Cancer Genetics and Cytogenetic, 12: 73–83 (1984).CrossRefGoogle Scholar
  2. 2.
    M.Shaham, Y. Becker and M.M. Cohen. A diffusable clastogenic factor in ataxia telangiectasia. Cytogenetic, cell genetic, 27: 155–161 (1980).CrossRefGoogle Scholar
  3. 3.
    I. Emerit and P. Cerutti. Clastogenic activity from Bloom’s fibroblast cultures. Proc. Natl. Acad. Sci. USA, 78: 1868–1872 (1981).CrossRefPubMedGoogle Scholar
  4. 4.
    I. Emerit. Chromosome breakage factors: origin and possible significance. Progr. Mutat. Res., 4: 61–74 (1982).Google Scholar
  5. 5.
    I. Emerit. Oxygen-derived free radicals and DNA damage in autoimmune diseases, in “Free Radicals, Aging and Degenerative Diseases.”, J.E. Johnson ed. Alan R.Liss, New York pages 307–324 (1986).Google Scholar
  6. 6.
    S.H. Khan and I. Emerit. Lipid peroxidation products and clastogenic material in culture media of human leukocytes exposed to the tumor promoter phorbol-myristate acetate. J.Free Rad. Biol. Med. 1: 443–449 (1985).CrossRefGoogle Scholar
  7. 7.
    I. Emerit, S.H. Khan, and P. Cerutti. Treatment of lymphocyte cultures with a hypoxanthine–xanthine oxidase system induces the formation of transferable clastogenic material. J.Free Rad. Biol. Med. 1: 51–57 (1985).CrossRefGoogle Scholar
  8. 8.
    I. Emerit, J.N. Fabiani, O. Ponzio, A. Murday, F. Lunel, A. Carpentier. Clastogenic factor in ischemia-reperfusion. The Annals of Thoracic Surgery, in press.Google Scholar
  9. 9.
    B.Johnston. Measurment of 02; secreted by monocytes and macrophages. In “Methods in Enzymology”, L.Packer ed. Academic Press Inc. New York 105: 215–220 (1984).Google Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Ingrid Emerit
    • 1
  • Arlette Levy
    • 1
  • Shahid Khan
    • 1
  1. 1.Institut biomédical des CordeliersUniversité Paris VIParisFrance

Personalised recommendations